{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:01:02Z","timestamp":1763535662180,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaad.2019.11.031","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:46:46Z","timestamp":1574279206000},"page":"752-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hydroa vacciniforme\u2013like lymphoma: Clinicopathologic description, treatment, and outcome"],"prefix":"10.1016","volume":"85","author":[{"given":"Ruzeng","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Elbendary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk M.","family":"Elston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.11.031_bib1","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV + lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaad.2019.11.031_bib2","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/DAD.0b013e3181c036de","article-title":"Atypical hydroa vacciniforme-like Epstein-Barr virus associated T\/NK-cell lymphoproliferative disorder","volume":"34","author":"Lee","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2019.11.031_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2019.11.031_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"278","article-title":"EBV+ T-cell lymphoma of childhood","author":"Quintanilla-Martinez","year":"2008"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219331226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219331226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:49Z","timestamp":1759273129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219331226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0190962219331226"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.11.031","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroa vacciniforme\u2013like lymphoma: Clinicopathologic description, treatment, and outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}